Evidence map›Paper›PMID 26136122›Full record

ArticlePLoS pathogens2015

Intraperitoneal Infection of Wild-Type Mice with Synthetically Generated Mammalian Prion.

Xinhe Wang, Gillian McGovern, Yi Zhang, Fei Wang, Liang Zha, Martin Jeffrey, Jiyan Ma

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Xinhe WangCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America; Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio, United States of America.
Gillian McGovernAnimal and Plant Health Agency, Lasswade Laboratory, Pentlands Science Park, Penicuik, Midlothian, Scotland.
Yi ZhangDepartment of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio, United States of America; Key Laboratory of Brain Functional Genomics (East China Normal University), Ministry of Education, Shanghai Key Laboratory of Brain Functional Genomics (East China Normal University), School of Life Sciences, East China Normal University, Shanghai, China.
Fei WangCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America; Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio, United States of America.
Liang ZhaDepartment of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio, United States of America.
Martin JeffreyAnimal and Plant Health Agency, Lasswade Laboratory, Pentlands Science Park, Penicuik, Midlothian, Scotland.
Jiyan MaCenter for Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan, United States of America; Department of Molecular and Cellular Biochemistry, Ohio State University, Columbus, Ohio, United States of America; Key Laboratory of Brain Functional Genomics (East China Normal University), Ministry of Education, Shanghai Key Laboratory of Brain Functional Genomics (East China Normal University), School of Life Sciences, East China Normal University, Shanghai, China.
The Ohio State University · USAnimal and Plant Health Agency · GBEast China Normal University · CN

Funding

To investigate the contributions of lipid membranes to prion diseaseR01NS060729 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MA, JIYAN, SUREWICZ, WITOLD K · 2008 to 2017
$4.5M
Molecular Mechanism of Prion StrainR01NS071035 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI MA, JIYAN · 2011 to 2015
$1.8M
NINDS NIH HHS R01 NS 060729NINDS NIH HHS R01 NS060729NINDS NIH HHS R01 NS071035
6 · The paper itself

Abstract

The prion hypothesis postulates that the infectious agent in transmissible spongiform encephalopathies (TSEs) is an unorthodox protein conformation based agent. Recent successes in generating mammalian prions in vitro with bacterially expressed recombinant prion protein provide strong support for the hypothesis. However, whether the pathogenic properties of synthetically generated prion (rec-Prion) recapitulate those of naturally occurring prions remains unresolved. Using end-point titration assay, we showed that the in vitro prepared rec-Prions have infectious titers of around 104 LD50/μg. In addition, intraperitoneal (i.p.) inoculation of wild-type mice with rec-Prion caused prion disease with an average survival time of 210-220 days post inoculation. Detailed pathological analyses revealed that the nature of rec-Prion induced lesions, including spongiform change, disease specific prion protein accumulation (PrP-d) and the PrP-d dissemination amongst lymphoid and peripheral nervous system tissues, the route and mechanisms of neuroinvasion were all typical of classical rodent prions. Our results revealed that, similar to naturally occurring prions, the rec-Prion has a titratable infectivity and is capable of causing prion disease via routes other than direct intra-cerebral challenge. More importantly, our results established that the rec-Prion caused disease is pathogenically and pathologically identical to naturally occurring contagious TSEs, supporting the concept that a conformationally altered protein agent is responsible for the infectivity in TSEs.

Indexed as

Disease Models, AnimalAnimalsImmunohistochemistryInjections, IntraperitonealMicePrion DiseasesPrionsRecombinant ProteinsPrionsRecombinant Proteins

Identifiers

PMID26136122
PMCPMC4489884
OpenAlexW757395972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.